Next Science Future Growth
Future criteria checks 2/6
Next Science is forecast to grow earnings and revenue by 47.6% and 30.6% per annum respectively while EPS is expected to grow by 58.9% per annum.
Key information
47.6%
Earnings growth rate
58.9%
EPS growth rate
Medical Equipment earnings growth | 16.0% |
Revenue growth rate | 30.6% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 21 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 50 | -2 | N/A | N/A | 1 |
12/31/2025 | 39 | -9 | N/A | N/A | 1 |
12/31/2024 | 28 | -11 | N/A | N/A | 1 |
6/30/2024 | 23 | -14 | -13 | -12 | N/A |
3/31/2024 | 23 | -15 | -14 | -14 | N/A |
12/31/2023 | 22 | -16 | -16 | -15 | N/A |
9/30/2023 | 19 | -15 | -15 | -14 | N/A |
6/30/2023 | 16 | -15 | -14 | -13 | N/A |
3/31/2023 | 14 | -14 | -13 | -13 | N/A |
12/31/2022 | 12 | -13 | -12 | -12 | N/A |
9/30/2022 | 11 | -12 | -12 | -12 | N/A |
6/30/2022 | 10 | -12 | -12 | -11 | N/A |
3/31/2022 | 10 | -11 | -10 | -10 | N/A |
12/31/2021 | 9 | -9 | -9 | -8 | N/A |
9/30/2021 | 8 | -9 | -10 | -9 | N/A |
6/30/2021 | 6 | -9 | -11 | -10 | N/A |
3/31/2021 | 5 | -11 | -12 | -11 | N/A |
12/31/2020 | 3 | -12 | -13 | -12 | N/A |
9/30/2020 | 3 | -12 | -12 | -11 | N/A |
6/30/2020 | 3 | -13 | -11 | -10 | N/A |
3/31/2020 | 3 | -13 | -13 | -11 | N/A |
12/31/2019 | 4 | -14 | -14 | -12 | N/A |
9/30/2019 | 4 | -15 | -14 | -13 | N/A |
6/30/2019 | 4 | -16 | -15 | -14 | N/A |
3/31/2019 | 4 | -15 | -14 | -13 | N/A |
12/31/2018 | 3 | -14 | -13 | -12 | N/A |
12/31/2017 | 4 | -2 | N/A | N/A | N/A |
12/31/2016 | 1 | -3 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NXS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NXS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NXS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NXS's revenue (30.6% per year) is forecast to grow faster than the Australian market (5.6% per year).
High Growth Revenue: NXS's revenue (30.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NXS's Return on Equity is forecast to be high in 3 years time